<DOC>
	<DOC>NCT03049059</DOC>
	<brief_summary>A Comparative study for Efficacy and Safety Between 4% hydroquinone cream with or without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma</brief_summary>
	<brief_title>A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma</brief_title>
	<detailed_description>Primary Objective: - To compare clinical efficacy by Modified MASI score between Fractional Picosecond 1,064 nm laser and daily application of 4% hydroquinone with 4% hydroquinone alone Secondary objectives - To compare the clinical endpoints of Mexameter Melanin Index, brownish spot and Ultraviolet spots by VISIATM complexion analysis, The Antera 3DÂ® imaging technology for pigmentation, quality of life by Dermatology Life Quality Index and patient's satisfaction between Fractional Picosecond 1,064 nm laser and 4% hydroquinone with 4% hydroquinone alone</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Hydroquinone</mesh_term>
	<criteria>Female with melasma lesion on bilateral sides Age between 1865 years Dermal or mixed type melasma, confirming by Wood's lamp test Willing to participant in this study and signed in informed consent form Pregnancy / lactation Having an activity or working outside the building or unable to avoid heavy UV light Allergic to UV sunscreen, topical anesthetics , topical corticosteroid or hydroquinone Treatment with laser or chemical peeling within 3 months Treatment with Skin Lighting medication / food supplements within 4 weeks Currently use of topical retinoid, hydroquinone or corticosteroid within 4 weeks Use of whitening cream such as alpha arbutin, azelaic acid, kojic acid ascorbic acid or any cosmetics within 2 weeks Uncontrolled medical illness include nonskin cancers, coagulopathy Intracardiac device pacemaker Photosentive conditions such as diabetes, thyroid disease, liver and kidney disease and photosensitive dermatosis Currently taking anticoagulant such as warfarin Active skin infection or acute dermatitis at testes skin sites Unable to follow and comply to the study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>